Recently published studies that examined discordance rates as a function of the molecular subtype of the primary tumor showed that HER2-low was more common in HR-positive tumors than in triple-negative tumors [22,32,52,59,67,68]. The gene discussed is ERBB2; the disease is neoplasm.